ANIXA BIOSCIENCES, INC. Proceeds from Issuance of Private Placement
ANIXA BIOSCIENCES, INC. (ANIX) reported Proceeds from Issuance of Private Placement of $3.50 million for the 9-month period ending 2014-07-31, per its 10-Q filed 2014-09-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2015-01-29
- ANIXA BIOSCIENCES, INC. proceeds from issuance of private placement for the quarter ending 2014-07-31 was $0.00.
- ANIXA BIOSCIENCES, INC. proceeds from issuance of private placement for the quarter ending 2011-10-31 was $0.00.
- ANIXA BIOSCIENCES, INC. proceeds from issuance of private placement for the quarter ending 2011-07-31 was $0.00.
- ANIXA BIOSCIENCES, INC. proceeds from issuance of private placement for fiscal 2012 was $750.00K, a 40.00% decline from fiscal 2011.
- ANIXA BIOSCIENCES, INC. proceeds from issuance of private placement for fiscal 2011 was $1.25M.
| Period end | Proceeds from Issuance of Private Placement | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|---|---|
| 2014-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $3.50M 10-Q · filed 2014-09-15 | ||||
| 2014-04-30 | $3.50M 10-Q · filed 2014-06-16 | |||||
| 2014-01-31 | $1.76M 10-Q · filed 2014-06-16 | |||||
| 2013-01-31 | $1.76M 10-Q · filed 2014-09-15 | |||||
| 2013-01-01 | $1.76M 10-K · filed 2015-01-29 | |||||
| 2012-10-31 | $750.00K 10-K · filed 2013-01-29 | |||||
| 2011-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $0.00 derived: sum of 2 quarters · filed 2013-01-29 | $1.25M 10-K · filed 2013-01-29 | |||
| 2011-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-14 | $1.25M 10-Q · filed 2012-09-14 | ||||
| 2011-04-30 | $1.25M 10-Q · filed 2012-06-14 | |||||
| 2011-02-28 | $1.25M 10-Q · filed 2012-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |